Recruiting OBSERVATIONAL NCT05451303

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

Detection of Oral and Throat Cancers Using Saliva Metatranscriptomic Analysis

Sponsor: New York Medical College

Conditions Oral Squamous Cell Carcinoma Oropharynx Squamous Cell Carcinoma Premalignant Lesion

Interventions OralViome Cancer Testing System

Updated 5 times since 2022 Last updated: Jan 27, 2025 Started: May 27, 2022 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Oral Squamous Cell Carcinoma and Oropharynx Squamous Cell Carcinoma and is currently actively recruiting participants. New York Medical College leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Feb 2025 — Present [monthly]

Recruiting
Sep 2024 — Feb 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2024 — Jul 2024 [monthly]

Recruiting
Sep 2022 — Jan 2024 [monthly]

Recruiting

First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

New York Medical College
Viome

Data source: Viome

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States